Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Levofloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for levofloxacin and what is the scope of levofloxacin patent protection?

is the generic ingredient in six branded drugs marketed by Rising Pharms Inc, Orchid Hlthcare, Hetero Labs Ltd V, Dr Reddys Labs Inc, Jubilant Generics, Aurobindo Pharma Ltd, Janssen Pharms, Torrent Pharms, Lupin, Watson Labs Teva, Claris, Sandoz, Macleods Pharms Ltd, Acs Dobfar Info Sa, Akorn, Glenmark Generics, Zydus Pharms Usa Inc, Sagent Pharms, Teva, Wockhardt, Santen, Fresenius Kabi Usa, Hikma Farmaceutica, Mylan, Hospira Inc, Hi Tech Pharma, Apotex Inc, Watson Labs Inc, Emcure Pharms Ltd, and Cipla Ltd, and is included in forty NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for levofloxacin. Sixty-four suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: levofloxacin

Drug Master File Entries: see list28
Suppliers / Packagers: see list64
Bulk Api Vendors: see list56
Clinical Trials: see list56
Patent Applications: see list5,795
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levofloxacin at DailyMed

Pharmacology for Ingredient: levofloxacin

Drug ClassQuinolone Antimicrobial

Tentative approvals for LEVOFLOXACIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe250MGTABLET; ORAL
► Subscribe► Subscribe750MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
TABLET;ORAL200250-003Jun 20, 2011ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
TABLET;ORAL201043-003Jun 20, 2011ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
TABLET;ORAL200250-001Jun 20, 2011ABRXNoNo► Subscribe► Subscribe
TABLET;ORAL076361-002Jun 20, 2011ABRXNoNo► Subscribe► Subscribe
Jubilant Generics
TABLET;ORAL203613-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus